Search

Abstract Recently, growing interest in polymers (natural and synthetic) as drug carriers in controlled release formulations and drug targeting systems that may improve the efficacy of treatment and reduce the side effects of a drug therapy, has been observed. Special attention has been paid to improving the effectiveness of antibiotics, which constitute a very important, often life-saving group of drugs. In this paper, we review polymers as macromolecular carriers of fluoroquinolones, a group of antibiotics with a broad spectrum of activity. We consider both physical intermixtures and chemical conjugates, although we discuss in greater depth the latter type of coupling, in which covalent bonds between drug molecules and polymers occur. Graphical abstract Unlabelled Image [ABSTRACT FROM AUTHOR]

Abstract: In biomedical field, a variety of natural or synthetic polymers are being exponentially developed and used in vivo to improve human health. In practical applications, these biopolymers would enter blood circulation directly or indirectly, positively or passively, rapidly or slowly. Blood is a special tissue of human body, which fulfills many important missions to sustain normal metabolism. The contact with blood of the biopolymers, which are seen as foreign substances by the body, would be harmful or even instantaneously lethal, depending on the nature and the dose of the biopolymers administered. Therefore, it is critical to clearly understand the potential influences of the foreign polymers on blood before the polymers are applied from the lab to bedside. In this review, we discuss the recent studies on the interactions of foreign, solubilized polymer molecules (excluding formed polymer materials) with blood constituents (red blood cells, white blood cells, platelets, plasma proteins, etc.), to gain insight into the potential in vivo applications of the biopolymers in the biomedical field. [Copyright &y& Elsevier]

Electrospun fiber mats are explored as drug delivery vehicles using tetracycline hydrochloride as a model drug. The mats were made either from poly(lactic acid) (PLA), poly(ethylene-co-vinyl acetate) (PEVA), or from a 50:50 blend of the two. The fibers were electrospun from chloroform solutions containing a small amount of methanol to solubilize the drug. The release of the tetracycline hydrochloride from these new drug delivery systems was followed by UV–VIS spectroscopy. Release profiles from the electrospun mats were compared to a commercially available drug delivery system, Actisite® (Alza Corporation, Palo Alto, CA), as well as to cast films of the various formulations. [Copyright &y& Elsevier]